8-K - Fate Therapeutics, Inc. | StockGist

Current Report Details

Event Type

Regulation Fd

Other Event

Exhibits Only

Disclosure

Voluntary

Variant

8-K

Items Reported

7.01

of this Current Report on Form 8-K, including Exhibit 99.1 attached hereto, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Ac

Regulation Fd

8.01

Other Events. FT819 iPSC-derived CAR T-cell Program On October 26, 2025, the Company (i) announced that 10 patients with treatment-refractory, moderate-to-sever

Other Event

9.01

Financial Statements and Exhibits. (d) Exhibits. Exhibit No. Description 99.1 Press Release dated October 26, 2025. 104 Cover Page Interactive Data File (embedd

Exhibits Only

Source Document

Exhibits (2)

8-K

99.1

EX-99.1